statistiche ricercatore

Continente	#
NA - Nord America	540
AS - Asia	453
EU - Europa	271
SA - Sud America	60
Continente sconosciuto - Info sul continente non disponibili	26
AF - Africa	20
Totale	1.370

Nazione	#
US - Stati Uniti d'America	522
SG - Singapore	131
VN - Vietnam	96
CN - Cina	92
IT - Italia	66
BD - Bangladesh	58
BR - Brasile	45
IE - Irlanda	44
DE - Germania	38
SE - Svezia	38
HK - Hong Kong	34
FR - Francia	21
ZA - Sudafrica	18
TR - Turchia	14
NL - Olanda	13
FI - Finlandia	11
GB - Regno Unito	8
BE - Belgio	6
CA - Canada	6
CZ - Repubblica Ceca	5
IN - India	5
AR - Argentina	4
AT - Austria	4
HN - Honduras	4
IQ - Iraq	4
JP - Giappone	4
MX - Messico	4
RU - Federazione Russa	4
ES - Italia	3
VE - Venezuela	3
AZ - Azerbaigian	2
BO - Bolivia	2
CO - Colombia	2
EC - Ecuador	2
JM - Giamaica	2
LT - Lituania	2
PH - Filippine	2
PL - Polonia	2
PY - Paraguay	2
BG - Bulgaria	1
CH - Svizzera	1
CI - Costa d'Avorio	1
EG - Egitto	1
GR - Grecia	1
ID - Indonesia	1
JO - Giordania	1
KG - Kirghizistan	1
KH - Cambogia	1
KR - Corea	1
LA - Repubblica Popolare Democratica del Laos	1
MT - Malta	1
MY - Malesia	1
NI - Nicaragua	1
OM - Oman	1
PA - Panama	1
RS - Serbia	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
UA - Ucraina	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.345

Nome	#
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value	206
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC)	196
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer	194
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME	170
Vaccines against coronaviruses: The state of the art	160
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer	154
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC	110
Analgosedation in Pediatric Emergency Care: A Comprehensive Scoping Review	94
An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children	86
Totale	1.370

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	36	0	2	1	2	2	3	4	2	2	3	3	12
2022/2023	181	15	22	9	17	15	22	3	11	51	1	12	3
2023/2024	71	1	4	2	2	4	16	5	4	6	9	8	10
2024/2025	235	5	9	19	23	21	21	19	17	21	15	22	43
2025/2026	670	62	40	69	52	90	32	36	25	108	44	63	49
2026/2027	36	22	14	0	0	0	0	0	0	0	0	0	0
Totale													1.370